ChatDocto
Find a doctor
Bottle of oral suspension

METRONIDAZOLE OPALIA 4,00%

Metronidazole · oral suspension

FL/120 mlOral use
5,050 DTRecorded public price · FL/120 ml
See all pack prices
Strength4,00%
Therapeutic classANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE
ATC codeJ01XD01

About this medicine

METRONIDAZOLE OPALIA 4,00% oral suspension is listed in Tunisia's medicine catalog under the active ingredient Metronidazole. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · FL/120 ml

    Recorded public price5,050 DT
    AMM No.
    9023611
    CNAM code
    300298
    CNAM reference amount
    5,040 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formoral suspension
Route of administrationOral use
LaboratoryOPALIA PHARMA
OriginGeneric
ScheduleA
ATC codeJ01XD01 — Métronidazole
Therapeutic classANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

TAMIZOL 4,00%Suspension buvableGALPHARMA · FL/125 ml
Recorded public price6,040 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026